GE Healthcare announced Pristina Via, a mammography system aimed at improving the screening experience for technicians and patients.
Pristina Via provides mammography technologists with a set of tools that balance the demands of diagnostic accuracy and rapid workflow to facilitate more patient-centered breast care.
As part of the Senographe Pristina platform, Pristina Via provides features that reduce repetitive tasks and simplify workflows so mammography technicians can focus on providing quality, personalized care during the screening process.
According to the company, no waiting time between shots allows technicians to work at their own pace, and vendor-neutral previous image comparisons reduce time spent analyzing previous exams. The final evaluation will be more efficient.
“Pristina Via represents a significant evolution of the patient-centric Senographe Pristina platform, designed by women, for women. With new in-room workflows, Pristina Via minimizes tedious work and gives technicians It gives us time to prioritize what matters most: compassion,” said Jyoti Gupta, president and CEO of Women’s Health and X-Ray at GE Healthcare. said in a statement.
bigger trends
Earlier this month, GE HealthCare and DeepHealth, a RadNet subsidiary, collaborated on new AI imaging technology to accelerate innovation, commercialization, and adoption of AI in imaging.
The companies will develop tools that leverage AI to address key bottlenecks across the imaging value chain, including increasing the efficiency of image interpretation and reporting, enabling collaboration between medical teams, improving clinical interpretation of images, and enhancing operational efficiency. We jointly developed a certain SmartTechnology. And productivity.
In October, GE Healthcare launched CareIntellect, a cloud application that combines multimodal patient data from different systems into a single view with the help of generative AI and gives clinicians access to notes and reports. for Oncology announced.
In July, GE Healthcare announced that it will use Amazon Web Services (AWS) Healthcare and genAI services to deliver AI-enabled workflows to improve diagnostic screening accuracy, streamline healthcare operations, and improve equitable healthcare access and outcomes. announced that they have entered into a strategic partnership to create
GE uses Amazon Bedrock’s foundational model to create its own genAI applications and modernize applications built on Amazon SageMaker. The company’s developers also use Amazon Q, an AI-powered assistant, to generate code suggestions and assist with software development.
In September, GE Healthcare’s competitor in mammography, Siemens Healthineers, received premarket approval from the FDA for its Mammomat B.brilliant tomosynthesis, or three-dimensional breast imaging technology.
This approval includes new 3D image acquisition and reconstruction techniques and adds to the capabilities of already approved systems for full-field digital mammography or 2-dimensional breast imaging, breast biopsy, and titanium-enhanced mammography. It was done.
Watch part 2 of this video interview.
